News

Introspections from an international resident following a US conference shed light on issues in geriatric psychiatry and more.

A new cognitive biotype for depression may impact symptoms and treatment outcomes.

Managed care has a new name…

In this CME article, learn more about the full continuum of presentations and variable trajectories typical of females with ADHD.

Tell us about your favorite hobby or leisure activity for a chance to be featured in our After Hours video series.

The temptation to see a charismatic figure as a “savior” undermines individual autonomy and threatens democracy.

"Systemic racism is insidious and ingrained in our daily experience. Women of color are doubly minoritized."

An interview with Brendon Stubbs, PhD.

“She would never hurt her baby...”

Here’s why you should try writing your own eulogy.

From a look at adolescent substance use to special challenges in treating borderline personality disorder during the perinatal period, here are highlights from the week in Psychiatric Times.

How does schizophrenia differ between men and women, and what does this mean for developing treatment strategies?

A difficult diagnosis...

"There is an urgency for competent, thoughtful mental health care for women—not only because the differences have been ignored in the past, but because women’s mental health so often affects health and mental health outcomes for their children."

“The described effects of ACD856 may improve cognition, increase resilience, and promote neurorestorative processes, thereby leading to a healthier brain in patients with [Alzheimer disease].”

Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.

"Psychiatry is in a real stew now, with every kind of foundational question up for grabs."

How can BPD traits affect the transition to parenthood?

"Although adolescent substance use is a topic that can be challenging for families and clinicians alike, data demonstrate that interventions during this time are effective for preventing, identifying, and reducing risky use."

The drug has shown statistically significant, clinically meaningful reductions in symptoms of depression, anhedonia.

Did you miss our APA Annual Meeting coverage?

Is forgiveness healing?

What is the association between the gut microbiome and response to SSRIs in patients with depression?

Trial results underscore the importance of early diagnosis and treatment in patients with Alzheimer disease.

This book asks us to reexamine anxiety…

Is hatred a mental health issue?

From noninvasive brain stimulation techniques for catatonia to the concurrent treatment of eating disorders and PTSD, here are highlights from the week in Psychiatric Times.

Let’s reach for the sky and beat back climate change.

Divinity and psychiatry: how do they connect? One psychiatrist shares his perspective.